Spinraza (Biogen)
Welcome to the PulseAid listing for the Spinraza drug offered from Biogen. This Survival Motor Neuron-2-directed RNA Interaction [EPC],Antisense Oligonucleotide [EPC],Oligonucleotides, Antisense [Chemical/Ingredient],Increased Protein Synthesis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Biogen |
NON-PROPRIETARY NAME: | Nusinersen |
SUBSTANCE NAME: | NUSINERSEN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Survival Motor Neuron-2-directed RNA Interaction [EPC],Antisense Oligonucleotide [EPC],Oligonucleotides, Antisense [Chemical/Ingredient],Increased Protein Synthesis [PE] |
ROUTE: | INTRATHECAL |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-12-23 |
END MARKETING DATE: | 0000-00-00 |
Spinraza HUMAN PRESCRIPTION DRUG Details:
Item Description | Spinraza from Biogen |
LABELER NAME: | Biogen |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2.4(mg/mL) |
START MARKETING DATE: | 2016-12-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 64406-058_1514085a-8cbb-4690-b477-fdf70f34d726 |
PRODUCT NDC: | 64406-058 |
APPLICATION NUMBER: | NDA209531 |
Other NUSINERSEN Pharmaceutical Manufacturers / Labelers: